Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 295, Issue 1, 2008, Pages

  Jeoung, Nam Ho ^a   Harris, Robert A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Branched chain amino acids; Diet induced obesity; Fatty acid oxidation; Glucose oxidation; Pyruvate dehydrogenase kinase 4 knockout mice

Indexed keywords

GLYCOGEN; PALMITIC ACID; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE 4; UNCLASSIFIED DRUG; INSULIN; PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID DIET; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PYRUVATE DEHYDROGENASE KINASE 4 DEFICIENCY; ANIMAL; BLOOD; C57BL MOUSE; DIAPHRAGM; ENZYMOLOGY; FAT INTAKE; FOOD DEPRIVATION; GLUCOSE TOLERANCE TEST; KIDNEY; LIVER; MALE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; BLOOD GLUCOSE; DIAPHRAGM; DIETARY FATS; FOOD DEPRIVATION; GLUCOSE TOLERANCE TEST; INSULIN; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; OBESITY; PROTEIN KINASES;

EID: 50349094001     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00536.2007     Document Type: Article

References (52)

1. Aicher TD, Anderson RC, Gao J, Shetty SS, Coppola GM, Stanton JL, Knorr DC, Sperbeck DM, Brand LJ, Vinluan CC, Kaplan EL, Dragland CJ, Tomaselli HC, Islam A, Lozito RJ, Liu X, Maniara WM, Fillers WS, DelGrande D, Walter RE, Mann WR. Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase. J Med Chem 43: 236-249, 2000.
2. Anderson JW, Karounos D, Yoneyama T, Hollingsworth JW. Dichloroacetate-induced changes in liver of normal and diabetic rats. Proc Soc Exp Biol Med 149: 814-821, 1975.
3. Bajotto G, Murakami T, Nagasaki M, Qin B, Matsuo Y, Maeda K, Ohashi M, Oshida Y, Sato Y, Shimomura Y. Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids. Metabolism 55: 317-323, 2006.
4. Barrera CR, Namihira G, Hamilton L, Munk P, Eley MH, Linn TC, Reed LJ. α-Keto acid dehydrogenase complexes. XVI. Studies on the subunit structure of the pyruvate dehydrogenase complexes from bovine kidney and heart. Arch Biochem Biophys 148: 343-358, 1972.
5. Batenburg JJ, Olson MS. Regulation of pyruvate dehydrogenase by fatty acid in isolated rat liver mitochondria. J Biol Chem 251: 1364-1370, 1976.
6. Bebernitz GR, Aicher TD, Stanton JL, Gao J, Shetty SS, Knorr DC, Strohschein RJ, Tan J, Brand LJ, Liu C, Wang WH, Vinluan CC, Kaplan EL, Dragland CJ, DelGrande D, Islam A, Lozito RJ, Liu X, Maniara WM, Mann WR. Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase. J Med Chem 43: 2248-2257, 2000.
7. Blackshear PJ, Holloway PA, Alberti KG. The metabolic effects of sodium dichloroacetate in the starved rat. Biochem J 142: 279-286, 1974.
8. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ, Dyck DJ. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18: 1144-1146, 2004.
9. Bowker-Kinley MM, Davis WI, Wu P, Harris RA, Popov KM. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J 329: 191-196, 1998.
10. Chokkalingam K, Jewell K, Norton L, Littlewood J, van Loon LJ, Mansell P, Macdonald IA, Tsintzas K. High-fat/low-carbohydrate diet reduces insulin-stimulated carbohydrate oxidation but stimulates nonoxidative glucose disposal in humans: an important role for skeletal muscle pyruvate dehydrogenase kinase 4. J Clin Endocrinol Metab 92: 284-292, 2007.
11. Czok R, Lamprecht W. Pyruvate, phosphoenolpyruvate and D-glycerate-2-phosphate. In: Methods of Enzymatic Analysis, edited by Bergmeyer HU. New York: Academic, 1974.
12. Dubé J, Goodpaster BH. Assessment of intramuscular triglycerides: contribution to metabolic abnormalities. Curr Opin Clin Nutr Metab Care 9: 553-559, 2006.
13. Eggstein M, Kuhlmann E. Triglycerids and glycerol: determination after alkaline hydrolysis. In: Methods of Enzymatic Analysis, edited by Bergmeyer HU. New York: Academic, 1974.
14. Fong JC, Schulz H. On the rate-determining step of fatty acid oxidation in heart. Inhibition of fatty acid oxidation by 4-pentenoic acid. J Biol Chem 253: 6917-6922, 1978.
15. Grassl M. L-Alanine: determination with GPT and LDH. In: Methods of Enzymatic Analysis, edited by Bergmeyer HU. New York: Academic, 1974.
16. Holness MJ, Kraus A, Harris RA, Sugden MC. Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding. Diabetes 49: 775-781, 2000.
17. Holness MJ, Smith ND, Bulmer K, Hopkins T, Gibbons GF, Sugden MC. Evaluation of the role of peroxisome-proliferator-activated receptor alpha in the regulation of cardiac pyruvate dehydrogenase kinase 4 protein expression in response to starvation, high-fat feeding and hyperthyroidism. Biochem J 364: 687-694, 2002.
18. Holness MJ, Sugden MC. Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem Soc Trans 31: 1143-1151, 2003.
19. Howarth FC, Qureshi MA, Gbewonyo AJ, Tariq S, Adeghate E. The progressive effects of a fat enriched diet on ventricular myocyte contraction and intracellular Ca2+ in the C57BL/6J mouse. Mol Cell Biochem 273: 87-95, 2005.
20. Huang B, Gudi R, Wu P, Harris RA, Hamilton J, Popov KM. Isoenzymes of pyruvate dehydrogenase phosphatase. DNA-derived amino acid sequences, expression, and regulation. J Biol Chem 273: 17680-17688, 1998.
21. Huang B, Wu P, Popov KM, Harris RA. Starvation and diabetes reduce the amount of pyruvate dehydrogenase phosphatase in rat heart and kidney. Diabetes 52: 1371-1376, 2003.
22. Jeoung NH, Sanghani PC, Zhai L, Harris RA. Assay of the pyruvate dehydrogenase complex by coupling with recombinant chicken liver arylamine N-acetyltransferase. Anal Biochem 356: 44-50, 2006.
23. Jeoung NH, Wu P, Joshi MA, Jaskiewicz J, Bock CB, Depaoli-Roach AA, Harris RA. Role of pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) in glucose homoeostasis during starvation. Biochem J 397: 417-425, 2006.
24. Kerbey AL, Randle PJ, Cooper RH, Whitehouse S, Pask HT, Denton RM. Regulation of pyruvate dehydrogenase in rat heart. Mechanism of regulation of proportions of dephosphorylated and phosphorylated enzyme by oxidation of fatty acids and ketone bodies and of effects of diabetes: role of coenzyme A, acetyl-coenzyme A and reduced and oxidized nicotinamide-adenine dinucleotide. Biochem J 154: 327-348, 1976.
25. Kohn MC, Achs MJ, Garfinkel D. Computer simulation of metabolism in pyruvate-perfused rat heart. III. Pyruvate dehydrogenase. Am J Physiol Regul Integr Comp Physiol 237: R167-R173, 1979.
26. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7: 45-56, 2008.
27. Livesey G, Lund P. Determination of branched-chain amino and keto acids with leucine dehydrogenase. Methods Enzymol 166: 3-10, 1988.
28. Lo S, Russell JC, Taylor AW. Determination of glycogen in small tissue samples. J Appl Physiol 28: 234-236, 1970.
29. Majer M, Popov KM, Harris RA, Bogardus C, Prochazka M. Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects. Mol Genet Metab 65: 181-186, 1998.
30. Mayers RM, Butlin RJ, Kilgour E, Leighton B, Martin D, Myatt J, Orme JP, Holloway BR. AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats. Biochem Soc Trans 31: 1165-1167, 2003.
31. Mayers RM, Leighton B, Kilgour E. PDH kinase inhibitors: a novel therapy for Type II diabetes? Biochem Soc Trans 33: 367-370, 2005.
32. Newberry EP, Xie Y, Kennedy SM, Luo J, Davidson NO. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology 44: 1191-1205, 2006.
33. Newsholme EA. Carbohydrate metabolism in vivo: regulation of the blood glucose level. Clin Endocrinol Metab 5: 543-578, 1976.
34. Olowe Y, Schulz H. Regulation of thiolases from pig heart. Control of fatty acid oxidation in heart. Eur J Biochem 109: 425-429, 1980.
35. Park R, Radosevich PR, Leach WJ, Seto P, Arieff AI. Metabolic effects of dichloroacetate in diabetic dogs. Am J Physiol Endocrinol Metab 245: E94-E101, 1983.
36. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
37. Randle PJ, Sugden PH, Kerbey AL, Radcliffe PM, Hutson NJ. Regulation of pyruvate oxidation and the conservation of glucose. Biochem Soc Symp: 47-67, 1978.
38. Ravindran S, Radke GA, Guest JR, Roche TE. Lipoyl domain-based mechanism for the integrated feedback control of the pyruvate dehydrogenase complex by enhancement of pyruvate dehydrogenase kinase activity. J Biol Chem 271: 653-662, 1996.
39. Saddik M, Gamble J, Witters LA, Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 268: 25836-25845, 1993.
40. Sparks LM, Xie H, Koza RA, Mynatt R, Bray GA, Smith SR. High-fat/low-carbohydrate diets regulate glucose metabolism via a long-term transcriptional loop. Metabolism 55: 1457-1463, 2006.
41. Staack H, Binstock JF, Schulz H. Purification and properties of a pig heart thiolase with broad chain length specificity and comparison of thiolases from pig heart and Escherichia coli. J Biol Chem 253: 1827-1831, 1978.
42. Stacpoole PW, Henderson GN, Yan Z, Cornett R, James MO. Pharmacokinetics, metabolism and toxicology of dichloroacetate. Drug Metab Rev 30: 499-539, 1998.
43. Stanley WC, Hernandez LA, Spires D, Bringas J, Wallace S, McCormack JG. Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate. J Mol Cell Cardiol 28: 905-914, 1996.
44. Stannard SR, Johnson NA. Insulin resistance and elevated triglyceride in muscle: more important for survival than "thrifty" genes? J Physiol 554: 595-607, 2004.
45. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 115: 1111-1119, 2005.
46. Williamson DH, Mellanby J, Krebs HA. Enzymic determination of D(-)-beta-hydroxybutyric acid and acetoacetic acid in blood. Biochem J 82: 90-96, 1962.
47. Woerle HJ, Meyer C, Dostou JM, Gosmanov NR, Islam N, Popa E, Wittlin SD, Welle SL, Gerich JE. Pathways for glucose disposal after meal ingestion in humans. Am J Physiol Endocrinol Metab 284: E716-E725, 2003.
48. Woerle HJ, Szoke E, Meyer C, Dostou JM, Wittlin SD, Gosmanov NR, Welle SL, Gerich JE. Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 290: E67-E77, 2006.
49. Wu P, Blair PV, Sato J, Jaskiewicz J, Popov KM, Harris RA. Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues. Arch Biochem Biophys 381: 1-7, 2000.
50. Wu P, Inskeep K, Bowker-Kinley MM, Popov KM, Harris RA. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes 48: 1593-1599, 1999.
51. Wu P, Sato J, Zhao Y, Jaskiewicz J, Popov KM, Harris RA. Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. Biochem J 329: 197-201, 1998.
52. Yount EA, Felten SY, O'Connor BL, Peterson RG, Powell RS, Yum MN, Harris RA. Comparison of the metabolic and toxic effects of 2-chloropropionate and dichloroacetate. J Pharmacol Exp Ther 222: 501-508, 1982.